← Back to Search

Spotlight AQ Platform for Type 1 Diabetes

N/A
Recruiting
Led By Mark Clements, MD
Research Sponsored by Children's Mercy Hospital Kansas City
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
16-25 years old
On any diabetes treatment
Must not have
Lack of capacity
<16 years old or >25 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months (approximately)
Awards & highlights

Summary

This trial compares a new survey platform called Spotlight AQ to the standard pre-clinic assessment for adolescents and young adults with Type 1 Diabetes. It aims to see if using the Spotlight AQ survey can help

Who is the study for?
This trial is for young people aged 16-25 with Type 1 Diabetes. Participants will use the Spotlight AQ survey before two standard clinic visits and provide feedback on their experience.
What is being tested?
The study is testing if the Spotlight AQ survey platform can improve A1c levels compared to usual care in young diabetics. It also evaluates user satisfaction from both patients and healthcare providers.
What are the potential side effects?
Since this trial involves a survey tool rather than a medical treatment, there are no direct physical side effects expected from participating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 16 and 25 years old.
Select...
I am currently receiving treatment for diabetes.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am unable to make my own medical decisions.
Select...
I am either younger than 16 or older than 25.
Select...
My mental health allows me to fully participate in a study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months (approximately)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months (approximately) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
HbA1c
Secondary study objectives
HCP satisfaction with the Spotlight survey
Participant satisfaction
T1D outcomes
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention (Spotlight AQ)Experimental Treatment1 Intervention
Spotlight AQ is an Artificial Intelligence (AI) powered adaptive survey which identifies the main concerns and gaps in patients tailored to their specific needs in preparation for clinic visits
Group II: Standard of CareActive Control1 Intervention
The pre-clinic survey typically given to patients before clinic visits at each institution

Find a Location

Who is running the clinical trial?

Children's Mercy Hospital Kansas CityLead Sponsor
251 Previous Clinical Trials
930,380 Total Patients Enrolled
Mark Clements, MDPrincipal InvestigatorChildren's Mercy
2 Previous Clinical Trials
450 Total Patients Enrolled
~0 spots leftby Oct 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top